NOVONESIS A/S NAM. B DK 2
NOVONESIS A/S NAM. B DK 2/ DK0060336014 /
NZM2
2024-06-25 12:30:44 PM
|
Chg.
+0.06
|
Volume |
Bid4:04:16 PM |
Ask4:04:16 PM |
Market Capitalization |
Dividend Y. |
P/E Ratio |
57.48EUR
|
+0.10%
|
0 Turnover: 0.00 |
57.82Bid Size: 630 |
58.02Ask Size: 630 |
16.2 bill.EUR |
- |
- |
Business description
Novozymes is the world leader in biological solutions. As the world’s largest provider of enzyme and microbial technologies, the company´s bioinnovation enables higher agricultural yields, low-temperature washing, energy-efficient production, renewable fuel and many other benefits.
Management board & Supervisory board
CEO |
Ester Baiget |
Management board |
Rainer Lehmann, Amy Byrick, Anders Lund, Claus Crone Fuglsang, Graziela Chaluppe dos Santos Malucelli, Morten Enggaard Rasmussen, Tina Sejersgård Fanø |
Supervisory board |
Cees de Jong, Andreas Hentze Knudsen, Anne Breum, Cees de Jong, Heine Dalsgaard, Jens Øbro, Kasim Kutay, Kim Stratton, Mathias Uhlén, Preben Nielsen, Sharon James |
Company data
Name: |
Novozymes A.S |
Address: |
Krogshoejvej 36,DK-2880 Bagsvaerd |
Phone: |
+45-44-460000 |
Fax: |
- |
E-mail: |
-
|
Internet: |
www.novozymes.com/ |
Industry: |
Biotechnology |
Sector: |
Biotechnology |
Sub sector: |
Biotechnology |
End of financial year: |
12-31 |
Free Float: |
74.50% |
IPO date: |
2000-11-20 |
Company calendar
CW 35 | 2024-08-28
Interim Report 2nd Quarter/6 Months
|
CW 45 | 2024-11-07
Interim Report 3rd Quarter/9 Months
|
CW 9 | 2025-02-26
4th Quarter/Annual Report
|
CW 14 | 2025-04-03
General Shareholder Meeting
|